AB-506

Biorbyt

AB-506

10

Research Use Only

98.00%

C21H18ClF2N5O3

461.85

AB-506 is a compound that serves as an orally administered inhibitor specifically targeting the hepatitis B virus (HBV) core protein to obstruct HBV replication. It achieves this by binding to the HBV core protein, accelerating capsid assembly, and hindering the encapsidation of HBV pre-genomic RNA (pgRNA). Consequently, AB-506 is utilized in the study of chronic hepatitis B (CHB).

C(NC1=CC(Cl)=C(F)C=C1)(=O)C2=C3C([C@@H](NC(OCC=4N=CN(C)N4)=O)CC3)=C(F)C=C2

-20°C

12352200